TITLE

New Strategies For Innovation In Global Health: A Pharmaceutical Industry Perspective

AUTHOR(S)
Witty, Andrew
PUB. DATE
January 2011
SOURCE
Health Affairs;Jan2011, Vol. 30 Issue 1, p118
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Diseases that disproportionately affect developing countries play a large role in stalling economic and social development. Pharmaceutical companies are driving crucial research into new vaccines and medicines; however, although there is an imperative for industry to research new therapies for diseases of the poor, the financial returns are often seen as limited. This is beginning to change. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases. The public and private sectors must work together to develop a wide range of innovative tools, partnerships, and approaches.
ACCESSION #
58784570

 

Related Articles

  • Economic Perspectives On The Advance Market Commitment For Pneumococcal Vaccines. SNYDER, CHRISTOPHER M.; BEGOR, WILLS; BERNDT, ERNST R. // Health Affairs;Aug2011, Vol. 30 Issue 8, p1508 

    Pharmaceutical companies have long been reluctant to invest in producing new vaccines for the developing world because they have little prospect of earning an attractive return. One way to stimulate such investment is the use of an advance market commitment, an innovative financing program that...

  • Vaccines As A Global Imperative--A Business Perspective. St├ęphenne, Jean // Health Affairs;Jun2011, Vol. 30 Issue 6, p1042 

    During the past thirty years, vaccines have experienced a renaissance. Advances in science, business, and distribution have transformed the field to the point where vaccines are recognized as a "best buy" in global health, a driver of pharmaceutical industry growth, and a key instrument of...

  • Revitalizing Pharmaceutical Innovation For Global Health. Hoffman, Steven J.; Pogge, Thomas // Health Affairs;Feb2011, Vol. 30 Issue 2, p367 

    A letter to the editor is presented regarding the article on access to medicine in the January 2011 issue.

  • Partnerships To Provide Care And Medicine For Chronic Diseases: A Model For Emerging Markets. Goroff, Michael; Reich, Michael R. // Health Affairs;Dec2010, Vol. 29 Issue 12, p2206 

    The challenge of expanding access to treatment and medicine for chronic diseases in emerging markets is both a public health imperative and a commercial opportunity. Cross-sector partnerships--involving a pharmaceutical manufacturer; a local health care provider; and other private, public, and...

  • Reducing the Burden of Cervical Cancer in the Developing World. Agrawal, Priya // Current Women's Health Reviews;Feb2011, Vol. 7 Issue 1, p59 

    Cervical cancer is the most common gynaecological cancer in developing countries. It is the single largest cause of life years lost to cancer in these settings, despite the existence of technology that could almost entirely prevent these deaths. Low-income countries face multiple challenges that...

  • Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa. Bishai, David M.; Champion, Claire; Steele, Michael E.; Thompson, Lindsay // Health Affairs;Jun2011, Vol. 30 Issue 6, p1058 

    The Meningitis Vaccine Project, a so-called product development partnership, developed a new vaccine against bacterial meningitis, an inflammation of brain tissues that causes an estimated 10,000 deaths among African children and young people each year. The vaccine--known as MenAfriVac and...

  • A Review Of Innovative International Financing Mechanisms To Address Noncommunicable Diseases. Meghani, Ankita; Basu, Sanjay // Health Affairs;Sep2015, Vol. 34 Issue 9, p1546 

    Noncommunicable diseases have become prevalent in low- and middle-income countries. A key question that remains unresolved is how to support the development of systems to prevent and treat noncommunicable disease through international financing mechanisms. We conducted a review of articles and...

  • Feds, pharma, investors must partner on vaccine.  // Hospital Infection Control & Prevention;Jan2013, Vol. 40 Issue 1, p3 

    The article discusses about an influenza report by the Center for Infectious Disease Research. Author also discusses about policy like vaccination offers substantially more protection for most of the population than being unvaccinated. Substantial financial risks and inadequate incentives create...

  • Despite Obstacles, Considerable Potential Exists For More Robust Federal Policy On Community Development And Health. Arcaya, Mariana; Briggs, Xavier de Souza // Health Affairs;Nov2011, Vol. 30 Issue 11, p2064 

    The implementation of the Affordable Care Act of 2010 and the Obama administration's urban policy create an opportunity to link community development with health in new and powerful ways. The administration's policy emphasizes improved access to and quality of care through coordinated local and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics